The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
A cytokine-mediated link between innate immunity, inflammation, and cancer
Open accessAbstract
It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After chronic stress breaks this balance through a long-term pro-inflammatory response, these cells and cytokines can act on all stages of tumor development, including initiation, promotion, malignant transformation, invasion, and metastasis through mutation, epigenetic modification, and regulation of the tumor microenvironment [(50, 51); Figure 3].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Research works printed but not linked: 12
- Shacter, 2002, Oncology., 16, 217
- Sehouli, 2002, Anticancer Res., 22, 3421
- Kitakata, 2002, Cancer Res., 62, 6682
- Gado, 2001, Haematologica., 86, 227
- Tartour, 1999, Cancer Res., 59, 3698
- Trinchieri, 2003, Nat. Rev., 3, 133
- Erdman, 2003, Cancer Res., 63, 6042
- Kohno, 2003, Cancer Res., 63, 5091
- Alas, 2001, Clin. Cancer Res., 7, 709
- Lech-Maranda, 2006, Eur. Cytokine Netw., 17, 60
- Parsons, 1995, Cancer Res., 55, 5548
- Engle, 2002, Cancer Res., 62, 6362
Cited by
Sorted by citations
Items 601–700 of 999
Modulators affecting the immune dialogue between human immune and colon cancer cells
Djaldetti, M. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i5.129 · Cited by 49
Djurić, Z. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.017 · Cited by 50
Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis
Gu, J., Hu, X., Shao, W., Ji, T., Yang, W., Zhuo, H., Jin, Z., Huang, H., Chen, J., Huang, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11049 · Cited by 48
The Association Between Lung Carcinoma and Tuberculosis
Čukić, V. (2017) · Medical Archives · doi:10.5455/medarh.2017.71.212-214 · Cited by 49
Chen, P., Zhu, Y., Wu, X., Gu, X., Xue, M., & Liang, X. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522001180 · Cited by 48
Hou, Y., Li, X., Yang, Y., Shi, H., Wang, S., & Gao, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1274431 · Cited by 48
Lu, J., Zeng, H., Liang, Z. T., Chen, L., Zhang, L.-Y., Zhang, H., Liu, H., Jiang, H., Shen, B., Huang, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14739 · Cited by 48
Jaiswal, P. K., Singh, V., Srivastava, P., & Mittal, R. D. (2013) · Gene · doi:10.1016/j.gene.2013.01.025 · Cited by 48
Inflammation Amplification by Versican: The First Mediator
Zhang, Z., Miao, L., & Wang, L. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13066873 · Cited by 49
Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention
Parida, S., & Mandal, M. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000023 · Cited by 48
Turner, N. H., Tran, B., Tran, P. V., Sinnathamby, M., Wong, H., Jones, I. T., Croxford, M. A., Desai, J., Tie, J., Field, K. M., et al. (2015) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2015.02.004 · Cited by 48
Wei, Y., Lan, Y., Tang, R.-G., Xu, Q.-Q., Huang, Y., Nong, H., & Huang, W. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.07.010 · Cited by 48
Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells
Chang, C.-J., Chien, Y., Lu, K., Chang, S., Chou, Y., Huang, C.-S., Chang, C.-H., Chen, K.-H., Chang, Y.-L., Tseng, L., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.024 · Cited by 48
Li, W., Wang, Y., Wang, X., He, Z., Liu, F., Zhi, W., Zhang, H., & Niu, X. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.013 · Cited by 48
Guo, C., Bi, J., Li, X., Lyu, J., Liu, X., Wu, X., & Liu, J. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127931 · Cited by 48
Meijer, J. M., Ogink, J., Kreike, B., Nuyten, D. S. A., de Visser, K. E., & Roos, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0482 · Cited by 48
RetractedHak, C. C. W., Rullan, A., Patin, E. C., Pedersen, M., Melcher, A. A., & Harrington, K. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.971959 · Cited by 50
Rahmani, A. H., Almatroudi, A., Khan, A. A., Babiker, A. Y., Alanezi, M., & Allemailem, K. S. (2022) · Molecules · doi:10.3390/molecules27228023 · Cited by 47
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 53
Circulating Levels of GDF15, MMP7 and miR-200c as a Poor Prognostic Signature in Gastric Cancer
Blanco, M., Tarrío, N., Reboredo, M., Haz‐Conde, M., García, J., Quindós, M., Figueroa, A., Antón-Aparicio, L. M., Calvo, L., & Valladares‐Ayerbes, M. (2014) · Future Oncology · doi:10.2217/fon.13.263 · Cited by 47
Immunotherapeutic strategies in kidney cancer—when TKIs are not enough
Biswas, S., & Eisen, T. G. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.91 · Cited by 47
Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer
Rajitha, B., Nagaraju, G. P., Shaib, W. L., Alese, O. B., Snyder, J. P., Shoji, M., Pattnaik, S., Alam, A., & El‐Rayes, B. F. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22492 · Cited by 48
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
Bryson, B. L., Junk, D. J., Cipriano, R., & Jackson, M. W. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1259037 · Cited by 47
Barajas-Gómez, B. A., Rosas‐Carrasco, Ó., Morales-Rosales, S. L., Pedraza-Vázquez, G., González‐Puertos, V. Y., Juárez‐Cedillo, T., García, J. A., López‐Díazguerrero, N. E., Damián‐Matsumura, P., Königsberg, M., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.12.001 · Cited by 48
Pantic, J. M., Jovanović, I., Radosavljevic, G. D., Arsenijević, N., Conlon, J. M., & Lukić, M. L. (2017) · Molecules · doi:10.3390/molecules22122071 · Cited by 48
Exosomes Function in Tumor Immune Microenvironment
Huang, Y., Liu, K., Li, Q., Yao, Y., & Wang, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-74470-4_7 · Cited by 48
Wang, L., Xie, Y., Yang, W., Yang, Z., Jiang, S., Zhang, C., & Zhang, G. (2019) · Scientific Reports · doi:10.1038/s41598-018-38466-7 · Cited by 47
Biomarkers in Vestibular Schwannoma–Associated Hearing Loss
Lassaletta, L., Calvino, M., Morales‐Puebla, J. M., Lapunzina, P. D., la Rosa, L. R., Varela‐Nieto, I., & Martínez‐Glez, V. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00978 · Cited by 47
Park, H. Y., Kang, D., Shin, S. H., Choi, H., Jang, S. H., Lee, C., Kim, H., Kwon, O. J., Rhee, C. K., & Cho, J. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202010-1240oc · Cited by 47
The Prodrug Platin‐A: Simultaneous Release of Cisplatin and Aspirin
Pathak, R., Marrache, S., Choi, J. H., Berding, T. B., & Dhar, S. (2014) · Angewandte Chemie · doi:10.1002/ange.201308899 · Cited by 47
Sharma, S., Dominguez, A. L., Hoelzinger, D. B., & Lustgarten, J. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0393-1 · Cited by 46
Ji, D.-B., Xu, B., Liu, J.-T., Ran, F.-X., & Cui, J.-R. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20762 · Cited by 45
Zhang, L., Wu, X., Luo, C., Chen, X., Yang, L., TAO, J., & Shi, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1458 · Cited by 48
Gastroprotective effect of esculin on ethanol-induced gastric lesion in mice
Li, W., Wang, Y., Wang, X., Zhang, H., He, Z., Zhi, W., Liu, F., & Niu, X. (2016) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12255 · Cited by 46
Grupp, S. A., & June, C. H. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_94 · Cited by 48
Computational Modeling of Interactions between Multiple Myeloma and the Bone Microenvironment
Wang, Y., Pivonka, P., Buenzli, P., Smith, D., & Dunstan, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027494 · Cited by 47
MSCs and inflammation: new insights into the potential association between ALCL and breast implants
Orciani, M., Sorgentoni, G., Torresetti, M., Primio, R. D., & Benedetto, G. D. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3745-8 · Cited by 45
Ahn, S., Cho, S., & Choi, N. (2021) · Marine Drugs · doi:10.3390/md19010026 · Cited by 45
Combination of Dacarbazine and Dimethylfumarate Efficiently Reduces Melanoma Lymph Node Metastasis
Valero, T., Steele, S., Neumüller, K., Bracher, A., Niederleithner, H., Pehamberger, H., Petzelbauer, P., & Loewe, R. P. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.368 · Cited by 45
Yang, Z., Dai, Q., Gu, Y., Guo, Q., & Gong, L. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02210.x · Cited by 45
Xu, Y., Zhao, Y., Xu, W., Luo, F., Wang, B., Li, Y., Pang, Y., & Liu, Q. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.06.017 · Cited by 45
Park, K., Yun, H., Quang, T.-H., Oh, H., Lee, D., Auh, Q., & Kim, E.-C. (2016) · Oncotarget · doi:10.18632/oncotarget.6873 · Cited by 45
Ishihara, H., Kondo, T., Omae, K., Takagi, T., Iizuka, J., Kobayashi, H., Hashimoto, Y., & Tanabe, K. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-1021-x · Cited by 45
Ma, X., Yan, F., Deng, Q., Li, F., Lu, Z., Liu, M., Wang, L., Conklin, D. J., McCracken, J., Srivastava, S., et al. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.5 · Cited by 44
Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer
Ling, H. H., Pan, Y., Fan, C., Tseng, W., Huang, J., Wu, T., Chou, W., Wang, C., Yeh, K., & Chang, P. (2019) · Nutrients · doi:10.3390/nu11040898 · Cited by 45
Hua, X., Chen, J., Yang, S., & Liang, C. Y. (2020) · Aging · doi:10.18632/aging.102746 · Cited by 45
Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs
Wienke, J., Brouwers, L., van der Burg, L. M., Mokrý, M., Scholman, R. C., Nikkels, P. G. J., van Rijn, B. B., & van Wijk, F. (2020) · JCI Insight · doi:10.1172/jci.insight.137926 · Cited by 43
An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas
Zhao, X., Laver, T., Hong, S. W., Twitty, G. B., DeVos, A., DeVos, M., Benveniste, E. N., & Nozell, S. E. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0346-y · Cited by 46
The Lung Microbiota and Lung Cancer: A Growing Relationship
Zerdan, M. B., Kassab, J. T., Meouchy, P., Haroun, E., Nehme, R., Zerdan, M. B., Fahed, G., Petrosino, M., Dutta, D., & Graziano, S. L. (2022) · Cancers · doi:10.3390/cancers14194813 · Cited by 46
Gui, Y., Yeganeh, M., Donates, Y.-C., Tobelaim, W.-S., Chababi, W., Mayhue, M., Yoshimura, A., Ramanathan, S., Saucier, C., & Ilangumaran, S. (2015) · Oncogene · doi:10.1038/onc.2015.20 · Cited by 44
Serwe, A., Rudolph, K., Anke, T., & Erkel, G. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9643-3 · Cited by 46
Narayanan, D., Nair, S. V., & Menon, D. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.12.012 · Cited by 44
Leukotriene B4 Creates a Favorable Microenvironment for Murine Melanoma Growth
Bachi, A. L. L., Kim, F. J. K., Nonogaki, S., Carneiro, C. R. W., Lopes, J. D., Jasiulionis, M. G., & Correa, M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0038 · Cited by 44
Hasan, S. K., & Sultana, S. (2015) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2015.1070225 · Cited by 46
Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy
Bilska, M., Pawłowska, A., Zakrzewska, E., Chudzik, A., Suszczyk, D., Gogacz, M., & Wertel, I. (2020) · Journal of Oncology · doi:10.1155/2020/8797683 · Cited by 47
Zhang, B., Jia, H., Liu, J., Yang, Z., Jiang, T., Tang, K., Li, D., Huang, C., Ma, J., Shen, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001876 · Cited by 44
Li, C., Ma, Q., Gao, X., Wang, X., & Zhang, B.-L. (2021) · Marine Drugs · doi:10.3390/md19100572 · Cited by 46
Wang, J. P., Kao, F., Wu, C., Hung, Y., Chao, Y., Chou, Y., & Li, C. (2014) · Cancer · doi:10.1002/cncr.29159 · Cited by 43
Laniti, D. D., Abbott, K. L., Mookerjee, A., Zhao, A., Kirby, P. S., Sandaltzopoulos, R., Powell, D. J., Lamazière, A., Siegel, D. L., Wolf, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028386 · Cited by 42
Glass, O., Inman, B. A., Broadwater, G., Courneya, K. S., Mackey, J. R., Goruk, S. D., Nelson, E. R., Jasper, J., Field, C. J., Bain, J. R., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.662 · Cited by 43
Kube, D., Hua, T.-D., von Bonin, F., Schoof, N., Zeynalova, S., Klöss, M., Gocht, D., Potthoff, B., Tzvetkov, M. V., Brockmöller, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5182 · Cited by 43
Herpesviruses: Hijacking the Ras signaling pathway
Filippakis, H., Spandidos, D. A., & Sourvinos, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.03.007 · Cited by 43
Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease
Yashiro, M. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3646-4 · Cited by 44
Biogenic terbium oxide nanoparticles as the vanguard against osteosarcoma
Iram, S., Khan, S., Ansary, A. A., Arshad, M., Siddiqui, S., Ahmad, E., Khan, R. H., & Khan, M. S. (2016) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2016.05.053 · Cited by 43
Lv, Q., Wu, K., Liu, F., Wu, W., Chen, Y., & Zhang, W. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4503 · Cited by 43
Zhang, Y., Roth, J. A., Yu, H., Ye, Y., Xie, K., Zhao, H., Chang, D. W., Huang, M., Li, H., Qu, J., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy132 · Cited by 43
Alfaro, C., Suárez, N., Martínez‐Forero, I., Palazón, A., Rouzaut, A., Solano, S., Feijoó, E., Gúrpide, A., Bolaños, E., Erro, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017922 · Cited by 46
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma
Paillet, J., Plantureux, C., Lévesque, S., Le Naour, J., Stoll, G., Sauvat, A., Caudana, P., Tosello Boari, J., Bloy, N., Lachkar, S., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200853 · Cited by 41
Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway
He, R., He, Y., Du, R., Liu, C., Chen, Z., Zeng, A., & Song, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115090 · Cited by 45
Targeting inflammation-induced transcription factor activation: an open frontier for glioma therapy
Sen, E. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.003 · Cited by 42
Milsom, C., Lee, C. R., Hackl, C., Man, S., & Kerbel, R. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071270 · Cited by 42
Chen, I.-H., Lai, Y., Wu, C., Chang, Y., Chu, C., Tsai, I., Sun, F., & Lu, Y. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0753-0 · Cited by 42
Liu, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i10.1362 · Cited by 42
Lupuţ, L., Licărete, E., Sesărman, A., Pătraș, L., Alupei, M. C., & Banciu, M. (2017) · Oncology Reports · doi:10.3892/or.2017.5466 · Cited by 42
Oral Neutrophils: Underestimated Players in Oral Cancer
Domnich, M., Riedesel, J., Pylaeva, E., Kürten, C. H. L., Buer, J., Lang, S., & Jabłońska, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565683 · Cited by 42
Ahirwar, D. K., Mandhani, A., & Mittal, R. D. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.03.005 · Cited by 42
Chen, J., de Mejı́a, E. G., & Wu, J. S. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf201335g · Cited by 42
Lancemaside A inhibits lipopolysaccharide‐induced inflammation by targeting LPS/TLR4 complex
Joh, E., & Kim, D. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22773 · Cited by 43
Berković, M. C., Čaćev, T., Ivković, T. C., Zjačić-Rotkvić, V., & Kapitanović, S. (2014) · Neuroendocrinology · doi:10.1159/000362339 · Cited by 41
Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling
Tan, X., Bhattacharyya, K. K., Dutta, S. K., Bamlet, W. R., Rabe, K. G., Wang, E., Smyrk, T. C., Oberg, A. L., Petersen, G. M., & Mukhopadhyay, D. (2015) · Pancreas · doi:10.1097/mpa.0000000000000308 · Cited by 41
NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions
Sharma, N., & Jha, S. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2123-8 · Cited by 41
Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment
Lotfi, R., Kaltenmeier, C., Lotze, M. T., & Bergmann, C. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000444941 · Cited by 42
Sugar-Borate Esters – Potential Chemical Agents in Prostate Cancer Chemoprevention
Scorei, I. R., & Popa, R. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990124 · Cited by 41
Martinez, R. M., Pinho-Ribeiro, F. A., Steffen, V. S., Caviglione, C. V., Fattori, V., Bussmann, A. J. C., Bottura, C., Fonseca, M. J. V., Vignoli, J. A., Baracat, M. M., et al. (2017) · Photochemical & Photobiological Sciences · doi:10.1039/c6pp00442c · Cited by 45
Benedicto, A., Márquez, J., Herrero, A., Olaso, E., Kołaczkowska, E., & Arteta, B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3823-2 · Cited by 42
Xuan, X., Zhou, J., Tian, Z., Lin, Y., Song, J. J., Ruan, Z., Ni, B., Zhao, H., & Yang, W. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02160-5 · Cited by 41
Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity
Persano, S., Das, P., & Pellegrino, T. (2021) · Cancers · doi:10.3390/cancers13112735 · Cited by 41
Effect of IL-12B , IL-2 , TGF-β1 , and IL-4 Polymorphism and Expression on Hepatitis B Progression
Saxena, R., Chawla, Y. K., Verma, I., & Kaur, J. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0043 · Cited by 41
Vered, M., Fürth, E., Shalev, Y., & Dayan, D. (2012) · Clinical Oral Investigations · doi:10.1007/s00784-012-0814-1 · Cited by 41
MK2 regulates the early stages of skin tumor promotion
Johansen, C., Vestergaard, C., Kragballe, K., Kollias, G. A., Gaestel, M., & Iversen, L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp238 · Cited by 40
Understanding the squamous cell carcinoma immune microenvironment
Saeidi, V., Doudican, N. A., & Carucci, J. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1084873 · Cited by 40
Goo, D., Choi, J., Ko, H., Choppa, V. S. R., Liu, G., Lillehoj, H. S., & Kim, W. K. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1269398 · Cited by 43
Multiplexed Cytokine Profiling of Serum for Detection of Colorectal Cancer
Pengjun, Z., Xinyu, W., Feng, G., Xinxin, D., Yulan, L., Li, J., Xingwang, J., Zhen-nan, D., & Yaping, T. (2013) · Future Oncology · doi:10.2217/fon.13.71 · Cited by 40
Setia, S., Nehru, B., & Sanyal, S. N. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.09.003 · Cited by 40
Omrane, I., Baroudi, O., Bougatef, K., Mézlini, A., Abidi, A., Medimegh, I., Stambouli, N., Ayari, H., Kourda, N., Uhrhammer, N. A., et al. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.01.002 · Cited by 40
Contribution of IL-33 to the Pathogenesis of Colorectal Cancer
Cui, G.-L., Yuan, A., Pang, Z., Zheng, W.-L., Li, Z.-F., & Goll, R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00561 · Cited by 33
The role of TNF-α in chordoma progression and inflammatory pathways
Güllüoğlu, Ş., Tüysüz, E. C., Şahin, M., Yaltırık, C. K., Kuşkucu, A., Özkan, F., Dalan, A. B., Şahi̇n, F., Türe, U., & Bayrak, Ö. F. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00454-y · Cited by 41
Liu, C., Shen, H., Li, Y., Shao, P., Soulika, A. M., Meng, X., Xing, L., Xia, Y., & Zhang, X. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.002 · Cited by 40
Song, Z., Bao, Y., Zhang, Y., Mi, X., Wu, P., Wu, Y., Yu, C., Sun, Y., Zheng, L., Huang, Y., et al. (2011) · Biochemical Journal · doi:10.1042/bj20101780 · Cited by 40
Dougan, M. L., & Dranoff, G. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im2011s85 · Cited by 40
Metadata
- Authors
- Lin, W.-W., & Karin, M.
- Affiliations
- National Taiwan University (TW)
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- Venue
- Journal of Clinical Investigation
- Published
- 2007-05-01
- Volume
- 117
- Issue
- 5
- Pages
- 1175-1183
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1857251
- OpenAlex
- W2133439754
- Cited by
- 1,940
- References
- 128
- Citations by year
- 2026: 18 · 2025: 39 · 2024: 60 · 2023: 92 · 2022: 93 · 2021: 117 · 2020: 117 · 2019: 102 · 2018: 93 · 2017: 123 · 2016: 104 · 2015: 127 · 2014: 134 · 2013: 130 · 2012: 124
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- cytokines, innate immunity, inflammation, cancer, chronic inflammation, tumor microenvironment, tumor promotion, tumor progression, infection and cancer, tumor initiation, inflammatory cells
- MeSH terms
- Animals, Humans, Immunity, Innate, Inflammation, Neoplasms, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review